Easing Digestive Health

Gastroenterology is a rich research environment, but it’s also competitive and changing at a rapid rate. As the landscape evolves with new emphasis on microbiome, researchers and clinicians are facing stringent requirements imposed by regulatory bodies on all phases of drug development for the treatment of gastroenterology disorders.

At Clinicorp Insights, our teams understand the gastroenterology research environment and the importance of moving your studies from startup to completion efficiently.

Learn more about our about our GI capabilities and experience below.

Study Capabilities and Experience

  • Constipation – multiple etiologies
  • Diarrhea
  • GI ulcers, including duodenal, peptic, and hemorrhagic
  • Anal fissures
  • Gastroesophageal reflux and esophagitis
  • Gastroparesis
  • Hepatitis, including viral (Hep B and Hep C)
  • Inflammatory bowel disease
    • Ulcerative colitis
    • Crohn’s disease
  • Irritable bowel syndrome
  • Mucositis
  • Pancreatitis
  • Vomiting (emesis)
  • Nutritional disorders and supplementation, both enteral and parenteral
  • Orphan and rare diseases, including:
    • Eosinophilic esophagitis
    • Behcet’s syndrome
    • Urea cycle disorder
    • Prader-Willi syndrome